Analyst Consensus ?
ConsensusBuy26 ratings
Bullish1765.4%
Neutral934.6%
Bearish00.0%
FN2 Earnings Intelligence
RTX Corporation analyst ratings
RTX Corporation (RTX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$198.12Previous close
$85Low
$174.47Average
$250High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Market Perform | Market Perform | Maintain | Aug 3, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 27, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 24, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 24, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jun 4, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 2, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 28, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 27, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 22, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2025 |
| Baird | Outperform | Neutral | Upgrade | Mar 19, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 2, 2025 |
| Alembic Global | Overweight | Neutral | Upgrade | Jul 30, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Nov 15, 2023 |
| DZ Bank | Hold | Buy | Downgrade | Sep 14, 2023 |
| Argus Research | Hold | Buy | Downgrade | Jul 31, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 26, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 12, 2023 |
| Vertical Research | Buy | Hold | Upgrade | Jul 10, 2020 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jun 2, 2020 |
| CFRA | Buy | Buy | Maintain | May 7, 2020 |
| Drexel Hamilton | Buy | Buy | Maintain | Mar 19, 2012 |
| Sterne Agee | Buy | Buy | Maintain | Mar 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $198.12. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Douglas Harned | $232 | $215.22 | +17.1% | Aug 3, 2026 |
| Argus Research | Analyst unavailable | $245 | $211.9 | +23.7% | Jul 30, 2026 |
| Deutsche Bank | Analyst unavailable | $238 | $217.52 | +20.1% | Jul 27, 2026 |
| Jefferies | Analyst unavailable | $250 | $212.79 | +26.2% | Jul 26, 2026 |
| RBC Capital | Analyst unavailable | $250 | $213.55 | +26.2% | Jul 24, 2026 |
| Susquehanna | Charles Minervino | $245 | $213.24 | +23.7% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $240 | $209.16 | +21.1% | Jul 24, 2026 |
| Morgan Stanley | Kristine Liwag | $240 | $209.16 | +21.1% | Jul 24, 2026 |
| UBS | Gavin Parsons | $215 | $209.16 | +8.5% | Jul 24, 2026 |
| Wells Fargo | Analyst unavailable | $230 | $209.16 | +16.1% | Jul 24, 2026 |
| Jefferies | Sheila Kahyaoglu | $220 | $172.55 | +11.0% | Jun 4, 2026 |
| Deutsche Bank | Scott Deuschle | $240 | $203.77 | +21.1% | Mar 5, 2026 |
| Bernstein | Analyst unavailable | $204 | $201.38 | +3.0% | Jan 29, 2026 |
| Jefferies | Sheila Kahyaoglu | $225 | $199.46 | +13.6% | Jan 28, 2026 |
| RBC Capital | Analyst unavailable | $230 | $200.88 | +16.1% | Jan 28, 2026 |
| Robert W. Baird | Peter Arment | $225 | $201.28 | +13.6% | Jan 28, 2026 |
| UBS | Gavin Parsons | $208 | $201.28 | +5.0% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $235 | $201.28 | +18.6% | Jan 28, 2026 |
| UBS | Analyst unavailable | $225 | $201.28 | +13.6% | Jan 27, 2026 |
| Vertical Research | Robert Stallard | $227 | $201.28 | +14.6% | Jan 27, 2026 |
| Susquehanna | Charles Minervino | $230 | $198.13 | +16.1% | Jan 15, 2026 |
| Bernstein | Analyst unavailable | $189 | $188.61 | -4.6% | Jan 6, 2026 |
| UBS | Analyst unavailable | $199 | $187.25 | +0.4% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $190 | $172.35 | -4.1% | Nov 25, 2025 |
| UBS | Gavin Parsons | $202 | $173.04 | +2.0% | Oct 22, 2025 |
| Morgan Stanley | Analyst unavailable | $215 | $173.04 | +8.5% | Oct 22, 2025 |
| Robert W. Baird | Peter Arment | $203 | $178 | +2.5% | Oct 22, 2025 |
| Susquehanna | Analyst unavailable | $205 | $173.04 | +3.5% | Oct 22, 2025 |
| Goldman Sachs | Noah Poponak | $168 | $173.04 | -15.2% | Oct 22, 2025 |
| Deutsche Bank | Analyst unavailable | $195 | $169.27 | -1.6% | Oct 8, 2025 |
| Bernstein | Douglas Harned | $181 | $166.58 | -8.6% | Oct 6, 2025 |
| Bernstein | Douglas Harned | $157 | $152.61 | -20.8% | Sep 10, 2025 |
| Bernstein | Douglas Harned | $154 | $146.87 | -22.3% | Jul 11, 2025 |
| Deutsche Bank | Scott Deuschle | $140 | $116.01 | -29.3% | Jan 2, 2025 |
| RBC Capital | Ken Herbert | $140 | $117.61 | -29.3% | Dec 19, 2024 |
| Deutsche Bank | Scott Deuschle | $131 | $125.43 | -33.9% | Oct 29, 2024 |
| Barclays | David Strauss | $130 | $125.43 | -34.4% | Oct 29, 2024 |
| Jefferies | Sheila Kahyaoglu | $120 | $127.21 | -39.4% | Oct 24, 2024 |
| Morgan Stanley | Kristine Liwag | $130 | $125.53 | -34.4% | Oct 23, 2024 |
| Susquehanna | Christopher Rolland | $150 | $125.53 | -24.3% | Oct 23, 2024 |
| RBC Capital | Ken Herbert | $130 | $125.53 | -34.4% | Oct 23, 2024 |
| UBS | Gavin Parsons | $133 | $125.53 | -32.9% | Oct 23, 2024 |
| Goldman Sachs | Noah Poponak | $113 | $125.53 | -43.0% | Oct 23, 2024 |
| Bank of America Securities | Ronald Epstein | $145 | $125.53 | -26.8% | Oct 23, 2024 |
| Deutsche Bank | Scott Deuschle | $129 | $123.67 | -34.9% | Oct 3, 2024 |
| Bank of America Securities | Ronald Epstein | $140 | $117.49 | -29.3% | Jul 31, 2024 |
| US Capital Advisors | Pete Skibitski | $134 | $116.88 | -32.4% | Jul 30, 2024 |
| RBC Capital | Ken Herbert | $115 | $114.98 | -42.0% | Jul 26, 2024 |
| RBC Capital | Ken Herbert | $102 | $104.99 | -48.5% | Jul 18, 2024 |
| Barclays | David Strauss | $100 | $102.44 | -49.5% | Apr 30, 2024 |
| Wells Fargo | Matthew Akers | $119 | $101.02 | -39.9% | Apr 25, 2024 |
| RBC Capital | Ken Herbert | $96 | $100.71 | -51.5% | Apr 19, 2024 |
| Jefferies | Sheila Kahyaoglu | $105 | $100.78 | -47.0% | Apr 11, 2024 |
| Wells Fargo | Matthew Akers | $120 | $97.53 | -39.4% | Apr 1, 2024 |
| RBC Capital | Ken Herbert | $82 | $75.1 | -58.6% | Sep 12, 2023 |
| Goldman Sachs | Analyst unavailable | $105 | $98.18 | -47.0% | Jan 13, 2023 |
| Credit Suisse | Analyst unavailable | $103 | $99.87 | -48.0% | Jan 12, 2023 |
| J.P. Morgan | Analyst unavailable | $107 | $98.78 | -46.0% | Dec 12, 2022 |
| Citigroup | Analyst unavailable | $104 | $99.63 | -47.5% | Dec 8, 2022 |
| Wells Fargo | Analyst unavailable | $98 | $90.27 | -50.5% | Jul 27, 2022 |
| Argus Research | John Eade | $112 | $94.91 | -43.5% | May 1, 2022 |
| Wells Fargo | Analyst unavailable | $106 | $99.19 | -46.5% | Apr 27, 2022 |
| RBC Capital | Ken Herbert | $125 | $102.11 | -36.9% | Apr 11, 2022 |
| Barclays | David Strauss | $107 | $97.04 | -46.0% | Mar 14, 2022 |
| Wolfe Research | Michael Maugeri | $111 | $94.36 | -44.0% | Feb 17, 2022 |
| Robert W. Baird | Peter Arment | $106 | $88.98 | -46.5% | Jan 26, 2022 |
| Credit Suisse | Robert Spingarn | $101 | $86.7 | -49.0% | Jul 27, 2021 |
| Cowen & Co. | Cai von Rumohr | $105 | $86.7 | -47.0% | Jul 27, 2021 |
| Langenberg & Co. | Brian Langenberg | $100 | $82.2 | -49.5% | May 3, 2021 |
| UBS | Myles Walton | $96 | $81.16 | -51.5% | Apr 28, 2021 |
| Capital One Financial | Jonathan Raviv | $85 | $81.16 | -57.1% | Apr 28, 2021 |
Track every rating change on RTX the moment it posts. Free to start.
Start free